Chardan

Chardan

John K. Chardan established Chardan in 1995, initially as a merchant bank focused on life sciences and technology. The firm has since expanded into capital markets advisory and private placements, working with early-stage and growth companies. Wealth origin is not publicly attributed to a single family; the firm operates as an independent partnership (per public record). Chardan's strategy spans public and private markets, including IPOs, follow-on offerings, PIPEs, and SPACs. The firm has advised on over 200 transactions, with a focus on healthcare, technology, life sciences, and energy. Known positions include serving as placement agent for several biotech and medtech companies, as well as lead manager for equity offerings in the energy sector. Geographic footprint covers North America, Europe, and Asia, with offices in New York, Miami, London, Wan Chai, Torino, and Dallas (per the firm's official communications). Chardan maintains a lean team of about 30 professionals across its offices. The firm does not disclose AUM, managing capital on a transaction-by-transaction basis with no commingled funds. Adjacent vehicles include no publicly known philanthropic foundation; the firm appears structured as a standalone investment bank without related entities. Chardan's structural differentiator lies in its dual capability as both a placement agent and a capital markets advisor, allowing it to source deals across both private and public stages. The firm avoids a sector-agnostic approach, concentrating on healthcare and technology where its team holds specific domain expertise.